## Abstract ## Background Nitric oxide is a major endogenous regulator of vascular tone. Inhaled nitric oxide gas has been investigated as a treatment for persistent pulmonary hypertension of the newborn. ## Objectives To determine whether treatment of hypoxaemic term and nearβterm newborn infan
Cochrane review: Inhaled nitric oxide for respiratory failure in preterm infants
β Scribed by Keith J Barrington; Neil Finer
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 344 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1557-6272
- DOI
- 10.1002/ebch.523
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Elevated pulmonary vascular resistance is seen in premature infants with severe respiratory distress syndrome (RDS). Inhaled nitric oxide (NO) has been shown to decrease pulmonary vascular resistance and to improve oxygenation in some patients with respiratory failure. The purpose of this study was
## Abstract ## Background Neonatal extracorporeal membrane oxygenation (ECMO) is a complex procedure of life support used in severe but potentially reversible respiratory failure in term infants. Although the number of babies eligible for ECMO is small and the use of ECMO invasive and potentially